Stockscreener 앱 받기
201.72
0.63%
1.0518
전일 마감가:
$200.67
열려 있는:
$200.05
하루 거래량:
1.37M
Relative Volume:
0.57
시가총액:
$43.00B
수익:
$447.02M
순이익/손실:
$-1.18B
주가수익비율:
-32.63
EPS:
-6.1812
순현금흐름:
$-906.14M
1주 성능:
+6.37%
1개월 성능:
+2.30%
6개월 성능:
+101.38%
1년 성능:
+173.45%
1일 변동 폭
$198.88
$205.23
1주일 범위
$189.77
$205.23
52주 변동 폭
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
201.64 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.59 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.11 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
872.32 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
390.82 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-04 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Why Insmed Incorporated stock is considered a top pickProduct Launch & AI Powered Market Entry Strategies - Bollywood Helpline
Insmed Impresses With Pulmonary Portfolio, But Still Lacks Remedy To Turn A Profit (NASDAQ:INSM) - Seeking Alpha
Wells Fargo Raises Price Target for Insmed (INSM) to $234 | INSM Stock News - GuruFocus
Cantor Fitzgerald Raises Price Target for INSM to $230 | INSM St - GuruFocus
Insmed heads to JPMorgan Healthcare Conference with treatment advancements - Traders Union
Insmed stock price target raised to $230 by Cantor Fitzgerald - Investing.com Canada
Insmed, Inc. $INSM Shares Sold by Hudson Bay Capital Management LP - MarketBeat
Goldman Sachs reiterates Buy rating on Insmed stock ahead of BiRCh trial - Investing.com Canada
Insmed (INSM) Receives Raised Price Target from Goldman Sachs | - GuruFocus
How Investors Are Reacting To Insmed (INSM) Joining The Nasdaq-100 Index - Yahoo Finance
Neuberger Berman Group LLC Sells 165,738 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Castleark Management LLC - MarketBeat
Goldman Sachs maintains Insmed (INSM) buy recommendation - MSN
NASDAQ adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22 - MSN
HRT Financial LP Takes Position in Insmed, Inc. $INSM - MarketBeat
Holocene Advisors LP Sells 9,616 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Boosted by Eventide Asset Management LLC - MarketBeat
Cubist Systematic Strategies LLC Takes $28.49 Million Position in Insmed, Inc. $INSM - MarketBeat
Brevan Howard Capital Management LP Takes Position in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Bellevue Group AG - MarketBeat
Alkeon Capital Management LLC Invests $50.32 Million in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Annual Changes to the Nasdaq-100 Index® - GlobeNewswire Inc.
Maverick Capital Ltd. Purchases 379,008 Shares of Insmed, Inc. $INSM - MarketBeat
California Public Employees Retirement System Trims Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Federated Hermes Inc. - MarketBeat
Insmed (INSM): Assessing Valuation After a Strong Year of Share Price Gains - Yahoo Finance
Is It Too Late to Consider Insmed After a 179% Surge and DCF Upside? - Yahoo Finance
Is the Market Bullish or Bearish on Insmed Inc? - Sahm
TD Cowen Raises Price Target for Insmed (INSM) to $269 | INSM Stock News - GuruFocus
Insmed (NASDAQ:INSM) Given New $269.00 Price Target at TD Cowen - MarketBeat
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks - AOL.com
HighVista Strategies LLC Reduces Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Acquired by Nebula Research & Development LLC - MarketBeat
Qube Research & Technologies Ltd Buys New Position in Insmed, Inc. $INSM - MarketBeat
Free cash flow per share of Insmed Incorporated – DUS:IM8N - TradingView — Track All Markets
TD Cowen raises Insmed stock price target to $269 on strong Brinsupri launch - Investing.com Canada
WINTON GROUP Ltd Purchases New Shares in Insmed, Inc. $INSM - MarketBeat
Stempoint Capital LP Sells 25,481 Shares of Insmed, Inc. $INSM - MarketBeat
CW Advisors LLC Buys Shares of 5,720 Insmed, Inc. $INSM - MarketBeat
INSMED Director Melvin Sharoky Sells 20,000 Shares - TradingView — Track All Markets
Insmed (Nasdaq: INSM) highlights TPIP, brensocatib data in ERS 2025 ALERT session - Stock Titan
Resolute Capital Asset Partners LLC Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Hsbc Holdings PLC Has $1.30 Million Stake in Insmed, Inc. $INSM - MarketBeat
B Group Inc. Sells 107,500 Shares of Insmed, Inc. $INSM - MarketBeat
Hood River Capital Management LLC Reduces Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Decreased by Kennedy Capital Management LLC - MarketBeat
Insmed, Inc. $INSM Shares Sold by Invesco Ltd. - MarketBeat
Guggenheim Capital LLC Acquires 5,945 Shares of Insmed, Inc. $INSM - MarketBeat
Jump Financial LLC Takes Position in Insmed, Inc. $INSM - MarketBeat
Bollard Group LLC Acquires New Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
0.93%
자본화:
|
볼륨(24시간):